Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Morphosys/Incyte’s Monjuvi Wins Early US FDA Approval In Second-Line DLBCL
MAb’s CAR-T Like Efficacy Seen Giving Wide Adoption
Aug 04 2020
•
By
Sten Stovall
MorphoSys, Incyte to co-commercialize Monjuvi in the US • Source: Shutterstock
More from New Products
More from Scrip